Tuesday, September 2, 2008
Dr. Robert Webber of DSX Therapeutics to Present - Friday, September 12th
Dr. Robert J. Webber is the founder and CEO of DSX Therapeutics, Inc. Dr. Webber was trained at the UCLA School of Medicine in the Department of Biological Chemistry. He was the founder, CEO and Chief Scientific Officer of Research & Diagnostic Antibodies®, the parent company of DSX Therapeutics, Inc. He is a pioneer in producing monoclonal antibodies, their use in diagnostic tests, and their utility as highly targeted treatments of disease. Dr. Robert Webber is the inventor or co-inventor of four issued patents and 13 pending US and foreign patent applications.